Tobramycin Inhalation Solution bulk supplier for pharma manufacturers

Tobramycin Inhalation Solution 300 mg/5 mL Suppliers & Bulk Manufacturers

Available Forms: Inhalation Solution

Available Strengths: 300 mg/5 mL

Reference Brands: Tobi (US)

Tobramycin inhalation inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, leading to bacterial cell death. It effectively reduces Pseudomonas infections in cystic fibrosis patients, offering rapid, targeted lung bacterial eradication, improved lung function, and reduced exacerbations with minimal systemic side effects when used properly.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Tobramycin Inhalation Solution? List it or send an offer →

Product Description: Tobramycin inhalation solution is approved in the EU and US for treating Pseudomonas aeruginosa infections in cystic fibrosis patients. In the EU, brands like Tobi are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. Due to its targeted lung delivery, strict guidelines on administration are enforced. We facilitate seamless market access in line with European and US standards for effective pulmonary infection management.

Tobramycin Inhalation Solution — third party manufacturing & bulk supply

Tobramycin Inhalation Solution 300 mg/5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tobramycin Inhalation Solution is supplied as Inhalation Solution — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tobramycin Inhalation Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tobramycin Inhalation Solution →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Tobramycin Inhalation Solution is listed as Inhalation Solution in 300 mg/5 mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Tobramycin Inhalation Solution is referenced against Tobi (US). Reference brands are shown for identification only and remain the property of their respective trademark owners.